|
Tumor microenvironment associated with increased pretreatment density of activated PD-1+ LAG-3+/− TIM-3− CD8+ T cells facilitates clinical response to axicabtagene ciloleucel (axi-cel) in patients (pts) with large B-cell lymphoma. |
| |
|
Stock and Other Ownership Interests - HalioDx |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Catalym; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Northwest Biotherapeutics; Roche; Sanofi |
Research Funding - AstraZeneca; ImageIQ; IO Biotech; Janssen; MedImmune; Perkin Elmer |
Patents, Royalties, Other Intellectual Property - Patent holder: INSERM |
| |
|
No Relationships to Disclose |
| |
|
|
| |
|
|
|
Stock and Other Ownership Interests - HalioDx |
Travel, Accommodations, Expenses - HalioDx |
| |
|
Stock and Other Ownership Interests - HalioDx |
| |
|
Stock and Other Ownership Interests - Cellular Biomedicine Group |
Consulting or Advisory Role - Alimera Sciences; Calibr; Celgene; Cellular Biomedicine Group; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Novartis; WUGEN, Inc. |
Research Funding - Kite, a Gilead company (Inst) |
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst) |
Travel, Accommodations, Expenses - Kite, a Gilead company |
| |
|
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences |
Consulting or Advisory Role - Alimera Sciences; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics |
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics |
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy |
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics |
| |
|
Consulting or Advisory Role - Adaptive Biotechnologies; Alimera Sciences; Janssen; Juno/Celgene; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics; Precision Biosciences |
Research Funding - Adaptive Biotechnologies; Alimera Sciences; Kite, a Gilead company; Novartis; Novartis; Pharmacyclics; Precision Biosciences; Roche/Genentech |
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim) |
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Juno Therapeutics; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics/Janssen |
| |
|
Honoraria - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences |
Consulting or Advisory Role - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences |
Speakers' Bureau - Axis Pharma; Clinical Care Options |
Research Funding - Pfizer |
Travel, Accommodations, Expenses - Celgene; Humanigen; Kite/Gilead; Novartis; Pfizer; Precision Biosciences |
| |
|
Consulting or Advisory Role - Incyte; Janssen; Jazz Pharmaceuticals |
| |
|
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst) |
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst) |
| |
|
|
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene; Kite/Gilead |
| |
|
|
Stock and Other Ownership Interests - Five Prime Therapeutics; Gilead Sciences |
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics |
Travel, Accommodations, Expenses - Kite/Gilead |
| |
|
Employment - Kite, a Gilead company |
| |
|
|
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
No Relationships to Disclose |
| |
|
Employment - Gilead Sciences; Kite/Gilead |
Stock and Other Ownership Interests - Gilead Sciences |
Consulting or Advisory Role - Gilead Sciences |
Travel, Accommodations, Expenses - Gilead Sciences |